Sean Elliott, MD
Urology · Minneapolis, MNNPI 1861435943
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $126,570 of the $163,467 with a category attached, or 77.4%. Laborie Medical Technologies Corp. accounts for 92.2% of it on its own, with 1 other manufacturer making up the rest. Reporting peaked in 2024 at $89,287 and has fallen 55.8% since, to $39,474 in 2025. Among urology clinicians in MN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 49 payments — averaging $3336.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Laborie Medical Technologies Corp.$151K
- Boston Scientific$13K
Across 12 payments — averaging $2556.71 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Urotronic, Inc$13K
- Laborie Medical Technologies Corp.$12K
- Boston Scientific$6K
What the payments were for
- Consulting fees$126,57077%
- Speaking & faculty fees$28,74618%
- Travel & lodging$6,9624%
- Food & beverage$1,1891%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Laborie Medical Technologies Corp. | 24 | $150,637 |
| Boston Scientific | 25 | $12,830 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$163,467 in reported general payments places this provider in the 95th percentile of 247 urology providers in Minnesota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 15 | $10,260 |
| GemtesaVibegron | 12 | $6,258 |
| Mirabegron ErMirabegron | 11 | $4,176 |
| Gentamicin Sulfate | 24 | $1,820 |
| Oxybutynin Chloride ErOxybutynin Chloride | 31 | $1,188 |
| Tolterodine Tartrate ErTolterodine Tartrate | 16 | $931 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 20 | $416 |
| Oxybutynin Chloride | 17 | $300 |
| Finasteride | 14 | $275 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 24 | $182 |
| Tamsulosin Hcl | 18 | $165 |
| Ciprofloxacin Hcl | 48 | $126 |
| Oxycodone Hcl | 20 | $41 |
Paid to pharmacies, not to this prescriber.
Other urology in Minneapolis
- Ayman SoubraMinneapolis$204K
- Nissrine NakibMinneapolis$86K
- Travis PagliaraMinneapolis$53K
- Badrinath KonetyMinneapolis$45K
- Christopher WeightMinneapolis$16K
- James AndersonMinneapolis$5K
- Joseph AcquayeMinneapolis$4K
- Joseph PariserMinneapolis$4K
- David YangMankato$298K
- Steven BernsteinEdina$271K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.